UM receives funding from The Gates Foundation for transformative family planning research in Africa and Pakistan
Funding will target improved availability and access to reproductive, maternal and newborn health services.
Funding will target improved availability and access to reproductive, maternal and newborn health services.
“The IGPH team is pleased to build on our work with healthcare providers to improve health outcomes for women, newborns and their families in expanded regions,” said James Blanchard. “Thanks to this significant funding provided by the Bill & Melinda Gates Foundation, our team will build new partnerships with local governments and health agencies with the goal of improved family planning practices.”
“The highlighted regions are characterized by low levels of, and slow increase in, the uptake of modern methods for family planning,” according to Blanchard. “Most of the regions have very little information about the supply and availability of family planning and maternal and newborn health services and commodities.”
“UM is grateful to the Bill & Melinda Gates Foundation for this important support that allows UM to continue to make positive impacts around the world,” said Dr. Mario Pinto, Vice-President (Research and International). “This grant allows Dr. Blanchard’s team to continue its valuable work helping to improve access to family planning and maternal, newborn and child healthcare in more regions. Collecting data from these unique geographies is an important step to furthering efforts that remove constraints and close gaps in the health care systems and improve the lives of women and their children.”
The Institute for Global Public Health (IGPH) was established in February 2020. It was based on the foundation built by the Centre for Global Public Health, which was created in 2008 to enhance the University of Manitoba’s leadership in global public health. IGPH is rooted in the Department of Community Health Sciences in the Rady Faculty of Health Sciences but has a university-wide mandate.
Research at the University of Manitoba is partially supported by funding from the Government of Canada Research Support Fund.
University of Manitoba researcher Dr. Nayara Rampazzo Morelli is pioneering new treatments that could delay the onset of Type 1 Diabetes.
A UM research team led by Dr. Soheila Karimi has found that the protein neuregulin-1 can halt multiple sclerosis in mice.
University of Manitoba researcher Dr. Nayara Rampazzo Morelli is pioneering new treatments that could delay the onset of Type 1 Diabetes.
A UM research team led by Dr. Soheila Karimi has found that the protein neuregulin-1 can halt multiple sclerosis in mice.
Robot dogs and smart technology among the care options showcased by Technology for Assisted Living lab.
UM ties with McMaster University for 5th ranking nationally, and leads amongst Prairie institutions